Christopher Wilfong is a Corporate Development and Strategy Advisor to IconOVir Bio. In addition, Mr. Wilfong is an Operating Partner at Two River Consulting, LLC, where he has been a co-founder and held senior leadership roles in multiple Two River portfolio companies, including Kite Pharma, Inc., Kronos Bio, Inc., and Neogene Therapeutics, Inc.
Prior to joining Two River, Mr. Wilfong was a Director at Trustbridge Partners, a China-based growth equity firm, where he led the US investment team and negotiated multiple US-China joint ventures and strategic partnerships in the healthcare and media industries. Prior to that, Mr. Wilfong was a Consultant at Bain & Company.
Mr. Wilfong received his B.S. in Economics magna cum laude from the Wharton School of the University of Pennsylvania, and received his M.B.A. from the MIT Sloan School of Management.